US Patent Issued to SOFAR SWISS on March 31 for "Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof" (Italian Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,071, issued on March 31, was assigned to SOFAR SWISS SA (Lugano, Switzerland).

"Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof" was invented by Andrea Biffi (Bologna, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and/or salts thereof."

The patent was filed on Feb. 26, 2024, under Application No. 18/586,970.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...